Non ci sono recensioni
A Brief History of the Discovery of
Pages 3-15
This book provides a detailed review of the most recent pathogenetic, diagnostic and therapeutic approaches in connection with Helicobacter pylori, along with priority areas in research and trends in clinical practice to address this significant pathogen acknowledged as the causative agent in a wide range of diseases, including gastric adenocarcinoma, MALT lymphoma and immune thrombocytopenic purpura (ITP). Medical authorities worldwide now recommend a “test and treat” strategy for this bacterial infection. Eradication therapy approaches range from general mass eradication therapy to tailor-made therapy for antibiotic-resistant refractory infection. In regions with high prevalence of H. pylori infection, the infection itself would be considered a major parameter to predict the risk of gastric adenocarcinoma development. The main interest has shifted recently to the risk stratification strategy for gastric cancer development and to the wide-ranging application of its serological prevention program.
This book will benefit all gastroenterologists, hematologists, dermatologists, primary care doctors, epidemiologists, physicians who related with community hygiene, as well as basic scientists, particularly microbiologists, bacteriologists, pathologists, molecular biologists, biochemists, immunologists and oncologists.
A Brief History of the Discovery of
Pages 3-15
Human Migration
Pages 19-32
CagA
Pages 33-47
Pages 49-66
Autophagy
Pages 67-71
Ghrelin and Gut Hormone
Pages 73-123
Symptom Generation
Pages 125-130
Gastric Non-
Pages 131-140
Urea Breath Test and Rapid Urease Test
Pages 143-155
Endoscopic Findings of
Pages 157-167
Stratification of Gastric Cancer Risk by
Pages 169-179
Prevention of Gastric Cancer by
Pages 181-202
Trends in Global Eradication Rates
Pages 205-223
Personalized Therapy in
Pages 225-235
Quadruple Regimens for
Pages 237-252
Third-Line Eradication Therapy
Pages 253-267
Sei sicuro di voler eseguire questa azione?